| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 15, 2006
From the Department of Cardiology, University Hospital of Tromsoe (T.K.S., J.M.), Tromsoe, Norway; Department of Cardiology, Skejby Sygehus, Aarhus University Hospital (M.M., J.R., J.F.L., L.T.), Aarhus, Denmark; Department of Cardiology, St. Olav Hospital (R.W.), Trondheim, Norway; Department of Cardiology, Paul Stradins Clinical Hospital (A.E., I.K., I.N.), Riga, Latvia; Feiring Heart Clinic (P.G.), Feiring, Norway; Department of Cardiology, Ullevaal University Hospital (O.M.), Oslo, Norway; Department of Cardiology, Haukeland University Hospital (S.R.), Bergen, Norway; Division of Cardiology, Department of Internal Medicine, University of Oulu (M.N., K.K.), Oulu, Finland; Department of Cardiology, Gentofte University Hospital (J.S.J., A.G.), Gentofte, Denmark; Department of Cardiology, Tampere University Hospital (K.N., S.V.), Tampere, Finland; Department of Cardiology, Uppsala University Hospital (S.J.), Uppsala, Sweden; Department of Cardiology, Aalborg University Hospital (J. Aarøe), Aalborg, Denmark; Department of Cardiology, Satakunta Central Hospital (A.Y.), Pori, Finland; Department of Cardiology, Rigshospitalet (S.H.), Copenhagen, Denmark; Department of Cardiology, Falun Hospital (I.S.), Falun, Sweden; Department of Cardiology, Odense University Hospital (P.T.), Odense, Denmark; Division of Cardiology, Helsinki University Central Hospital (K.V.), Helsinki, Finland; Division of Cardiology, Kuopio University Central Hospital (M.P.), Kuopio, Finland; and Division of Cardiology, Turku University Central Hospital (J. Airaksinen), Turku, Finland. * To whom correspondence should be addressed. E-mail: leif.thuesen{at}ki.au.dk.
Background--The optimal stenting strategy in coronary artery bifurcation lesions is unknown. In the present study, a strategy of stenting both the main vessel and the side branch (MV+SB) was compared with a strategy of stenting the main vessel only, with optional stenting of the side branch (MV), with sirolimus-eluting stents. Methods and Results--A total of 413 patients with a bifurcation lesion were randomized. The primary end point was a major adverse cardiac event: cardiac death, myocardial infarction, target-vessel revascularization, or stent thrombosis after 6 months. At 6 months, there were no significant differences in rates of major adverse cardiac events between the groups (MV+SB 3.4%, MV 2.9%; P=NS). In the MV+SB group, there were significantly longer procedure and fluoroscopy times, higher contrast volumes, and higher rates of procedure-related increases in biomarkers of myocardial injury. A total of 307 patients had a quantitative coronary assessment at the index procedure and after 8 months. The combined angiographic end point of diameter stenosis >50% of main vessel and occlusion of the side branch after 8 months was found in 5.3% in the MV group and 5.1% in the MV+SB group (P=NS). Conclusions--Independent of stenting strategy, excellent clinical and angiographic results were obtained with percutaneous treatment of de novo coronary artery bifurcation lesions with sirolimus-eluting stents. The simple stenting strategy used in the MV group was associated with reduced procedure and fluoroscopy times and lower rates of procedure-related biomarker elevation. Therefore, this strategy can be recommended as the routine bifurcation stenting technique.
Revised on September 28, 2006
Accepted on October 3, 2006
Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions. The Nordic Bifurcation Study
Terje K. Steigen MD,
This article has been cited by other articles:
![]() |
F Zhang, L Dong, and J Ge Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: a meta-analysis of randomised trials Heart, October 15, 2009; 95(20): 1676 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Katritsis, G. C.M. Siontis, and J. P.A. Ioannidis Double Versus Single Stenting for Coronary Bifurcation Lesions: A Meta-Analysis Circ Cardiovasc Interv, October 1, 2009; 2(5): 409 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verheye, P. Agostoni, C. L. Dubois, J. Dens, J. Ormiston, S. Worthley, B. Trauthen, T. Hasegawa, B.-K. Koo, P. J. Fitzgerald, et al. 9-Month Clinical, Angiographic, and Intravascular Ultrasound Results of a Prospective Evaluation of the Axxess Self-Expanding Biolimus A9-Eluting Stent in Coronary Bifurcation Lesions: The DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) Study J. Am. Coll. Cardiol., March 24, 2009; 53(12): 1031 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Latib, A Colombo, and G M Sangiorgi Bifurcation stenting: current strategies and new devices Heart, March 15, 2009; 95(6): 495 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Galassi, S. D. Tomasello, D. Capodanno, G. Barrano, G. P. Ussia, and C. Tamburino Mini-Crush Versus T-Provisional Techniques in Bifurcation Lesions: Clinical and Angiographic Long-Term Outcome After Implantation of Drug-Eluting Stents J. Am. Coll. Cardiol. Intv., March 1, 2009; 2(3): 185 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Kaplan Percutaneous Coronary Intervention Treatment of Bifurcation Lesions--A Work in Progress: The Importance of Single-Center Studies J. Am. Coll. Cardiol. Intv., March 1, 2009; 2(3): 195 - 196. [Full Text] [PDF] |
||||
![]() |
P. S. Teirstein Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis Circulation, February 24, 2009; 119(7): 1021 - 1033. [Full Text] [PDF] |
||||
![]() |
A. Colombo, E. Bramucci, S. Sacca, R. Violini, C. Lettieri, R. Zanini, I. Sheiban, L. Paloscia, E. Grube, J. Schofer, et al. Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations: The CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study Circulation, January 6, 2009; 119(1): 71 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Price, D. E. Kandzari, and P. S. Teirstein Change We Can Believe In: The Hyper-Evolution of Percutaneous Coronary Intervention for Unprotected Left Main Disease With Drug-Eluting Stents Circ Cardiovasc Interv, December 1, 2008; 1(3): 164 - 166. [Full Text] [PDF] |
||||
![]() |
M. Ferenc, M. Gick, R.-P. Kienzle, H.-P. Bestehorn, K.-D. Werner, T. Comberg, P. Kuebler, H. J. Buttner, and F.-J. Neumann Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions Eur. Heart J., December 1, 2008; 29(23): 2859 - 2867. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Lassen Two stent or not two stent--that is the question Eur. Heart J., December 1, 2008; 29(23): 2829 - 2830. [Full Text] [PDF] |
||||
![]() |
T. Adriaenssens, R. A. Byrne, A. Dibra, R. Iijima, J. Mehilli, O. Bruskina, A. Schomig, and A. Kastrati Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes Eur. Heart J., December 1, 2008; 29(23): 2868 - 2876. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Katritsis and B. Meier Percutaneous Coronary Intervention for Stable Coronary Artery Disease J. Am. Coll. Cardiol., September 9, 2008; 52(11): 889 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
Shaoliang Chen, Junjie Zhang, Fei Ye, Zhongsheng Zhu, Song Lin, Nailiang Tian, Zhizhong Liu, Weiyi Fang, Yundai Chen, Xuewen Sun, et al. Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation Lesions Angiology, August 1, 2008; 59(4): 475 - 483. [Abstract] [PDF] |
||||
![]() |
J. A. Ormiston, M. W.I. Webster, B. Webber, J. T. Stewart, P. N. Ruygrok, and R. I. Hatrick The "Crush" Technique for Coronary Artery Bifurcation Stenting: Insights From Micro-Computed Tomographic Imaging of Bench Deployments J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 351 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Routledge, M.-C. Morice, T. Lefevre, P. Garot, F. De Marco, B. Vaquerizo, and Y. Louvard 2-Year Outcome of Patients Treated for Bifurcation Coronary Disease With Provisional Side Branch T-Stenting Using Drug-Eluting Stents J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 358 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Waksman and L. Bonello The 5 Ts of Bifurcation Intervention: Type, Technique, Two Stents, T-Stenting, Trials J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 366 - 368. [Full Text] [PDF] |
||||
![]() |
A. Latib and A. Colombo Bifurcation Disease: What Do We Know, What Should We Do? J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 218 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-K. Koo, K.-W. Park, H.-J. Kang, Y.-S. Cho, W.-Y. Chung, T.-J. Youn, I.-H. Chae, D.-J. Choi, S.-J. Tahk, B.-H. Oh, et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve Eur. Heart J., March 2, 2008; 29(6): 726 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Brilakis and P. B. Berger Treatment of coronary bifurcations: might less be more? Eur. Heart J., March 2, 2008; 29(6): 704 - 706. [Full Text] [PDF] |
||||
![]() |
P. S. Teirstein Unprotected left main intervention patient selection, operator technique, and clinical outcomes. J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 5 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Melikian and W Wijns Drug-eluting stents: a critique Heart, February 1, 2008; 94(2): 145 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tsuchikane, T. Aizawa, H. Tamai, Y. Igarashi, K. Kawajiri, N. Ozawa, S. Nakamura, K. Oku, M. Kijima, T. Suzuki, et al. Pre Drug-Eluting Stent Debulking of Bifurcated Coronary Lesions J. Am. Coll. Cardiol., November 13, 2007; 50(20): 1941 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Windecker and B. Meier Late Coronary Stent Thrombosis Circulation, October 23, 2007; 116(17): 1952 - 1965. [Full Text] [PDF] |
||||
![]() |
A. Colombo and A. Chieffo Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Unsettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease) Circulation, September 18, 2007; 116(12): 1424 - 1432. [Full Text] [PDF] |
||||
![]() |
A. Erglis, I. Narbute, I. Kumsars, S. Jegere, I. Mintale, I. Zakke, U. Strazdins, and A. Saltups A Randomized Comparison of Paclitaxel-Eluting Stents Versus Bare-Metal Stents for Treatment of Unprotected Left Main Coronary Artery Stenosis J. Am. Coll. Cardiol., August 7, 2007; 50(6): 491 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A.G. Van Mieghem, A. Thury, W. B. Meijboom, F. Cademartiri, N. R. Mollet, A. C. Weustink, G. Sianos, P. P.T. de Jaegere, P. W. Serruys, and P. de Feyter Detection and characterization of coronary bifurcation lesions with 64-slice computed tomography coronary angiography Eur. Heart J., August 2, 2007; 28(16): 1968 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., July 17, 2007; 50(3): 270 - 285. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |